Zirabev 400 MG/16 ML vial 16ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,399
Award facts
- Contract value 100% obligated
- $29,398.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,398.55 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 12, 2026, for the supply of Zirabev 400 mg/16 ml vials. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of January 13, 2026. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical supply agreement valued at up to $999,999,999.00 and extending through December 2031.
Zirabev is a bevacizumab biosimilar used in oncology treatment protocols, and this procurement supports the military healthcare system's pharmaceutical supply requirements. AmerSourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, routinely fulfills delivery orders across multiple therapeutic domains including specialty medications, biologics, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio and established relationship with DLA as a pharmaceutical prime vendor position it to efficiently deliver essential cancer care medications to military treatment facilities and related healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FCY9Q?
SPE2DR26FCY9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FCY9Q worth?
The government has obligated $29,399 on SPE2DR26FCY9Q.
Is contract SPE2DR26FCY9Q an order under another contract?
Yes. SPE2DR26FCY9Q is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY9Q competed?
The extent of competition for SPE2DR26FCY9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award